Analysts See $-0.01 EPS for Acerus Pharmaceuticals Corporation (ASP)

Rusty Cady

Analysts expect Acerus Pharmaceuticals Corporation (TSE:ASP) to report $-0.01 EPS on May, 11.They anticipate $0.00 EPS change or 0.00 % ...

EPS for Everspin Technologies, Inc. (MRAM) Expected At $-0.43

Rusty Cady

Analysts expect Everspin Technologies, Inc. (NASDAQ:MRAM) to report $-0.43 EPS on May, 11.They anticipate $0.06 EPS change or 12.24 % ...

Analysts See $-0.22 EPS for J. C. Penney Company, Inc. (JCP)

Linda Rogers

Investors sentiment decreased to 0.82 in 2017 Q4. Its down 0.37, from 1.19 in 2017Q3. It dived, as 47 investors ...

EPS for Hydrogenics Corporation (HYGS) Expected At $-0.11

Henry Gaston

Investors sentiment decreased to 1.64 in Q4 2017. Its down 1.03, from 2.67 in 2017Q3. It dropped, as 3 investors ...

Fennec Pharmaceuticals Inc. (FENC) Analysts See $-0.14 EPS

Henry Gaston

Analysts expect Fennec Pharmaceuticals Inc. (NASDAQ:FENC) to report $-0.14 EPS on May, 11.They anticipate $0.08 EPS change or 133.33 % ...

EPS for Celsion Corporation (CLSN) Expected At $-0.30

simple simple

Analysts expect Celsion Corporation (NASDAQ:CLSN) to report $-0.30 EPS on May, 11.They anticipate $1.38 EPS change or 82.14 % from ...

Aptevo Therapeutics Inc. (APVO) Analysts See $-0.56 EPS

Dolores Ford

Analysts expect Aptevo Therapeutics Inc. (NASDAQ:APVO) to report $-0.56 EPS on May, 11.They anticipate $0.08 EPS change or 16.67 % ...

EPS for ADMA Biologics, Inc. (ADMA) Expected At $-0.27

Darrin Black

Investors sentiment increased to 3 in Q4 2017. Its up 1.86, from 1.14 in 2017Q3. It is positive, as 4 ...

« Previous PageNext Page »